2025-04-24 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Analysis Report

**0. Key Figures Summary:**

UNH's cumulative return significantly lags behind the S&P 500 (VOO) over the analyzed period.  While UNH shows positive growth, its performance is considerably lower than the market benchmark.  Recent price action suggests a downward trend, with the stock trading below its 5, 20, and 60-day moving averages.  RSI and PPO indicators point towards bearish sentiment.  Earnings show some volatility, but generally positive revenue growth.


**1. Performance Comparison with S&P 500 (VOO):**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company offering a range of health benefits and related services.

* **UNH Cumulative Return:** 42.56%
* **VOO (S&P 500) Cumulative Return:** 78.93%
* **Return Difference:** -36.4%
* **Relative Divergence:** 7.1% (This indicates UNH's underperformance relative to the S&P 500 falls within the lower 7.1% of historical divergence based on the provided min/max range of -43.3% to 53.4%)


**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 67.0% | 55.4% | 0.1 | 180.1 |
| 2016-2018  | 59.0% | 63.7% | 0.2 | 206.3 |
| 2017-2019  | 45.0% | 63.7% | 0.4 | 247.6 |
| 2018-2020  | -17.0% | 63.7% | 0.6 | 300.2 |
| 2019-2021  | 39.0% | 61.0% | 0.7 | 435.9 |
| 2020-2022  | 32.0% | 66.9% | 0.7 | 466.1 |
| 2021-2023  | 39.0% | 67.8% | 0.4 | 469.8 |
| 2022-2024  | -27.0% | 69.0% | 0.3 | 458.5 |
| 2023-2025  | -44.0% | 75.0% | 0.2 | 389.5 |

The data shows fluctuating CAGR and alpha values, indicating variable performance relative to the market (Beta).  The MDD (Maximum Drawdown) highlights significant periods of downside risk.  Market cap grew substantially during this period.


**2. Recent Price Action:**

* **Closing Price:** $427.96
* **5-Day Moving Average:** $463.92
* **20-Day Moving Average:** $526.30
* **60-Day Moving Average:** $511.23

The closing price is significantly below all three moving averages, suggesting a downtrend.  The small daily price change (+$0.18) does not indicate a significant reversal from this trend.


**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.4174 (Medium Risk)
* **RSI:** 33.43 (Suggests oversold conditions, but not a strong buy signal on its own)
* **PPO:** -3.42 (Negative value indicates bearish momentum)
* **Recent Relative Divergence:** -46.3% (Significant short-term divergence, reinforcing downtrend)
* **Expected Return (vs. S&P 500):** 163.8% (Long-term, 2+ years, potentially significant outperformance if the market corrects)


**4. Recent Earnings Analysis:**

| 날짜       | EPS      | 매출            |
|------------|----------|-----------------|
| 2024-11-04 | 6.56     | $100.82B        |
| 2024-08-09 | 4.58     | $98.86B        |
| 2024-05-09 | -1.53    | $99.80B        |
| 2023-11-06 | 6.31     | $92.36B        |
| 2024-11-04 | 6.31     | $92.36B        | *(Duplicate entry, likely an error)*


Revenue shows consistent growth, although EPS is volatile with a significant loss in Q2 2024.  The duplicate entry needs clarification.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue      | Profit Margin |
|---------|--------------|---------------|
| 2024-12-31 | $100.81B    | 21.14%        |
| 2024-09-30 | $100.82B    | 22.84%        |
| 2024-06-30 | $98.86B     | 22.31%        |
| 2024-03-31 | $99.80B     | 23.05%        |
| 2023-12-31 | $94.43B     | 23.30%        |

Revenue remains strong and relatively stable. Profit margins are healthy but show some fluctuation.


**Capital and Profitability:**

| Quarter | Equity       | ROE           |
|---------|--------------|---------------|
| 2024-12-31 | $92.66B     | 5.98%         |
| 2024-09-30 | $94.53B     | 6.41%         |
| 2024-06-30 | $89.36B     | 4.72%         |
| 2024-03-31 | $86.69B     | -1.63%        |
| 2023-12-31 | $88.76B     | 6.15%         |

Equity fluctuates, mirroring the profit margin. A negative ROE in Q1 2024 is concerning and requires further investigation.


**6. Overall Analysis:**

UNH shows mixed signals.  While revenue and profitability remain strong, the stock's underperformance relative to the S&P 500 and negative technical indicators suggest a bearish outlook in the short-term. The significant negative relative divergence and the negative PPO value indicate downward momentum.  The large negative difference in the cumulative return and high expected return are contradictory and need further investigation.  Clarification on the duplicate earnings data and the reasons behind the negative ROE in Q1 2024 are crucial for a complete assessment. The long-term outlook might be more positive, but cautious approach is recommended given the current market conditions and technical indicators.  Further analysis of the negative ROE and the data discrepancies is essential before making any investment decisions.
